Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design
第二代和第三代 BCR-ABL 酪氨酸激酶抑制剂与肺动脉高压风险:一项针对新用户的普遍研究
期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.125.077764
Jambon-Barbara, Clément; Suissa, Samy; Dell'Aniello, Sophie; Hlavaty, Alex; Cracowski, Jean-Luc; Chaumais, Marie-Camille; Humbert, Marc; Montani, David; Khouri, Charles